STK17A | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	39 studies	50% ± 17%	Explore
B cell	37 studies	42% ± 12%	Explore
CD8-positive, alpha-beta T cell	37 studies	46% ± 16%	Explore
T cell	34 studies	41% ± 14%	Explore
CD4-positive, alpha-beta T cell	32 studies	45% ± 14%	Explore
mature NK T cell	22 studies	42% ± 18%	Explore
naive B cell	20 studies	48% ± 16%	Explore
gamma-delta T cell	19 studies	45% ± 21%	Explore
regulatory T cell	19 studies	40% ± 12%	Explore
memory B cell	17 studies	47% ± 13%	Explore
CD16-negative, CD56-bright natural killer cell, human	16 studies	57% ± 22%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	37% ± 13%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	46% ± 19%	Explore
mucosal invariant T cell	14 studies	38% ± 14%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	45% ± 16%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	53% ± 20%	Explore
type I pneumocyte	11 studies	33% ± 11%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	43% ± 19%	Explore
effector memory CD8-positive, alpha-beta T cell	11 studies	48% ± 19%	Explore
endothelial cell	11 studies	20% ± 4%	Explore
basal cell	11 studies	38% ± 16%	Explore
ciliated cell	10 studies	28% ± 15%	Explore
innate lymphoid cell	8 studies	45% ± 16%	Explore
leukocyte	8 studies	40% ± 13%	Explore
astrocyte	8 studies	25% ± 8%	Explore
conventional dendritic cell	8 studies	19% ± 2%	Explore
T follicular helper cell	8 studies	49% ± 9%	Explore
epithelial cell	8 studies	34% ± 15%	Explore
type II pneumocyte	6 studies	18% ± 2%	Explore
CD4-positive helper T cell	6 studies	37% ± 21%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	6 studies	29% ± 12%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	45% ± 9%	Explore
plasmacytoid dendritic cell	6 studies	23% ± 7%	Explore
microglial cell	6 studies	28% ± 9%	Explore
exhausted T cell	5 studies	55% ± 17%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	37% ± 14%	Explore
lymphocyte	5 studies	49% ± 20%	Explore
abnormal cell	5 studies	35% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	48% ± 13%	Explore
oligodendrocyte precursor cell	5 studies	25% ± 9%	Explore
plasmablast	4 studies	22% ± 9%	Explore
precursor B cell	4 studies	24% ± 7%	Explore
immature B cell	4 studies	41% ± 6%	Explore
germinal center B cell	4 studies	45% ± 14%	Explore
fibroblast	4 studies	19% ± 4%	Explore
secretory cell	4 studies	34% ± 16%	Explore
double negative thymocyte	4 studies	39% ± 19%	Explore
mast cell	3 studies	19% ± 4%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	27% ± 4%	Explore
classical monocyte	3 studies	19% ± 3%	Explore
platelet	3 studies	19% ± 4%	Explore
hematopoietic precursor cell	3 studies	20% ± 2%	Explore
myeloid cell	3 studies	21% ± 4%	Explore
plasma cell	3 studies	27% ± 7%	Explore
intraepithelial lymphocyte	3 studies	53% ± 8%	Explore
glutamatergic neuron	3 studies	32% ± 10%	Explore
dendritic cell	3 studies	34% ± 11%	Explore
pancreatic ductal cell	3 studies	38% ± 8%	Explore
group 3 innate lymphoid cell	3 studies	53% ± 7%	Explore
T-helper 17 cell	3 studies	44% ± 10%	Explore
T-helper 1 cell	3 studies	54% ± 7%	Explore
erythrocyte	3 studies	37% ± 8%	Explore
smooth muscle cell	3 studies	18% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	16 studies	31% ± 10%	Explore
lung	12 studies	26% ± 11%	Explore
brain	6 studies	22% ± 9%	Explore
liver	4 studies	33% ± 6%	Explore
breast	3 studies	22% ± 3%	Explore
prostate	3 studies	40% ± 9%	Explore
lymph node	3 studies	56% ± 8%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	1207.61	1444 / 1445	100%	30.84	183 / 183
lung	100%	2442.00	577 / 578	100%	33.28	1155 / 1155
ovary	100%	1239.64	180 / 180	99%	14.79	425 / 430
uterus	100%	802.41	170 / 170	99%	27.33	453 / 459
breast	100%	1155.11	459 / 459	99%	20.05	1103 / 1118
pancreas	99%	1022.04	325 / 328	99%	23.61	177 / 178
bladder	100%	1107.05	21 / 21	97%	21.97	491 / 504
intestine	100%	1613.37	966 / 966	96%	15.92	508 / 527
stomach	100%	1489.96	358 / 359	97%	15.53	276 / 286
brain	96%	826.34	2529 / 2642	100%	34.17	705 / 705
thymus	100%	998.82	651 / 653	96%	14.49	580 / 605
kidney	99%	957.19	88 / 89	96%	17.45	868 / 901
prostate	100%	1164.44	244 / 245	95%	10.65	477 / 502
skin	99%	1485.64	1796 / 1809	95%	25.53	447 / 472
adrenal gland	100%	1679.74	257 / 258	89%	13.29	205 / 230
liver	90%	659.05	203 / 226	75%	10.79	305 / 406
adipose	100%	1424.61	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	73.64	29 / 29
spleen	100%	3781.78	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	31.28	45 / 45
ureter	0%	0	0 / 0	100%	10.72	1 / 1
peripheral blood	100%	4256.39	928 / 929	0%	0	0 / 0
blood vessel	100%	2105.80	1330 / 1335	0%	0	0 / 0
muscle	96%	1030.78	773 / 803	0%	0	0 / 0
heart	92%	1292.76	795 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	28%	1.94	22 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_2000271	Biological process	positive regulation of fibroblast apoptotic process
GO_0006915	Biological process	apoptotic process
GO_2000377	Biological process	regulation of reactive oxygen species metabolic process
GO_0006468	Biological process	protein phosphorylation
GO_0035556	Biological process	intracellular signal transduction
GO_0043065	Biological process	positive regulation of apoptotic process
GO_0016607	Cellular component	nuclear speck
GO_0005886	Cellular component	plasma membrane
GO_0005634	Cellular component	nucleus
GO_0004674	Molecular function	protein serine/threonine kinase activity
GO_0106310	Molecular function	protein serine kinase activity
GO_0005524	Molecular function	ATP binding

IV. Literature review

[source]

Gene name	STK17A
Protein name	Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) Uncharacterized protein STK17A
Synonyms	DRAK1
Description	FUNCTION: Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species. .
Accessions	Q86UI9 Q75MK4 Q9UEE5 ENST00000648544.1 ENST00000319357.6

STK17A report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review